These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 24418861)

  • 61. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
    Furlong MA; Fanburg-Smith JC
    Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Rhabdomyosarcoma: molecular analysis of Igf2, MyoD1 and Myogenin expression.
    Krskova L; Augustinakova A; Drahokoupilova E; Sumerauer D; Mudry P; Kodet R
    Neoplasma; 2011; 58(5):415-23. PubMed ID: 21744995
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epithelioid rhabdomyosarcoma: a clinicopathological study of seven additional cases supporting a distinctive variant with aggressive biological behaviour.
    Yu L; Lao IW; Wang J
    Pathology; 2015 Dec; 47(7):667-72. PubMed ID: 26517641
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence.
    Li JJ; Kovach AR; DeMonia M; Slemmons KK; Oristian KM; Chen C; Linardic CM
    Sci Rep; 2021 Aug; 11(1):16505. PubMed ID: 34389744
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry.
    Wachtel M; Runge T; Leuschner I; Stegmaier S; Koscielniak E; Treuner J; Odermatt B; Behnke S; Niggli FK; Schäfer BW
    J Clin Oncol; 2006 Feb; 24(5):816-22. PubMed ID: 16391296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Primary cutaneous rhabdomyosarcoma: a clinicopathologic review of 11 cases.
    Marburger TB; Gardner JM; Prieto VG; Billings SD
    J Cutan Pathol; 2012 Nov; 39(11):987-95. PubMed ID: 22994900
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation.
    Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F
    Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic evaluation of metastatic rhabdomyosarcoma in effusion specimens.
    Alderman MA; Thomas DG; Roh MH
    Diagn Cytopathol; 2013 Nov; 41(11):955-9. PubMed ID: 23584957
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Rhabdomyosarcomas: structural distribution and analysis of an immunohistochemical profile].
    Botiralieva GK; Sharlai AS; Roshchin VY; Sidorov IV; Konovalov DM
    Arkh Patol; 2020; 82(5):33-41. PubMed ID: 33054030
    [TBL] [Abstract][Full Text] [Related]  

  • 70. FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.
    de Traux De Wardin H; Cyrta J; Dermawan JK; Guillemot D; Orbach D; Aerts I; Pierron G; Antonescu CR
    Genes Chromosomes Cancer; 2024 Apr; 63(4):e23232. PubMed ID: 38607246
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel PAX3-NCOA1 Fusions in Biphenotypic Sinonasal Sarcoma With Focal Rhabdomyoblastic Differentiation.
    Huang SC; Ghossein RA; Bishop JA; Zhang L; Chen TC; Huang HY; Antonescu CR
    Am J Surg Pathol; 2016 Jan; 40(1):51-9. PubMed ID: 26371783
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.
    Basma H; Ghayad SE; Rammal G; Mancinelli A; Harajly M; Ghamloush F; Dweik L; El-Eit R; Zalzali H; Rabeh W; Pisano C; Darwiche N; Saab R
    Int J Cancer; 2016 Mar; 138(6):1528-37. PubMed ID: 26453552
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
    de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
    JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
    Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A new human pleomorphic rhabdomyosarcoma cell-line, HS-RMS-1, exhibiting MyoD1 and myogenin.
    Sonobe H; Takeuchi T; Taguchi T; Shimizu K; Furihata M; Ohtsuki Y
    Int J Oncol; 2000 Jul; 17(1):119-25. PubMed ID: 10853028
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases.
    Chrisinger JSA; Wehrli B; Dickson BC; Fasih S; Hirbe AC; Shultz DB; Zadeh G; Gupta AA; Demicco EG
    Virchows Arch; 2020 Nov; 477(5):725-732. PubMed ID: 32556562
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MYOD1 as a prognostic indicator in rhabdomyosarcoma.
    Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytogenetic-clinicopathologic correlations in rhabdomyosarcoma: a report of five cases.
    Chen Z; Coffin CM; Smith LM; Issa B; Arndt S; Shepard R; Brothman L; Stratton J; Brothman AR; Zhou H
    Cancer Genet Cytogenet; 2001 Nov; 131(1):31-6. PubMed ID: 11734315
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
    Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
    Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mechanisms of impaired differentiation in rhabdomyosarcoma.
    Keller C; Guttridge DC
    FEBS J; 2013 Sep; 280(17):4323-34. PubMed ID: 23822136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.